2025-04-28 15:35 SAK |
Food: 177g R slit open (do not remove GIT) Meloxicam: 1.25 ml (1.5 mg/ml soln) PO
|
2025-04-28 09:32 SAK |
======= TREATMENT PLAN ======= Food: 180g R slit open (do not remove GIT) SID Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM on 2025-04-30, 2025-05-04, 2025-05-08, 2025-05-12, 2025-05-16 Meloxicam: 1.25 ml (1.5 mg/ml soln) SID PO ==============================
|
2025-04-27 10:54 BT |
Food: 180g R slit open (do not remove GIT)
|
2025-04-26 08:40 BT |
Food: 180g R slit open (do not remove GIT) Ceftiofur 0.37 ml IM
|
2025-04-25 15:26 BT |
Group entry: 4 animals 150g M, Ch, R, Q per bird in PM
VitaHawk: Friday Only: Sprinkle 1/2 teaspoon per bird on food in PM.
|
2025-04-24 15:26 BT |
Group entry: 4 animals 150g M, Ch, R, Q per bird in PM
VitaHawk: Friday Only: Sprinkle 1/2 teaspoon per bird on food in PM.
|
2025-04-23 15:42 BT |
Group entry: 4 animals 150g M, Ch, R, Q per bird in PM
VitaHawk: Friday Only: Sprinkle 1/2 teaspoon per bird on food in PM.
|
2025-04-23 10:20 re |
Based on CT findings, we plan to give a course of Ceftiofur 100mg/mL (injection) for possible infection.
Imagery report |
Date | 2025-04-22 | Type | CT | Performed by | | Positioning | Whole body | Equipment | | Location | Whole body | Anesthesia | Midazolam + Dexemedetomidine | Comments | R carpal joint swelling and lytic changes associated with the articular surfaces of the ulna, radius, and radiocarpal joint are most concerning for a septic process, but does not rule out severe chronic synovitis. This is likely the cause of the patient's R wing abnormalities. Healed R tibiotarsal and fibular fractures were noted. |
|
|
2025-04-22 16:25 AN |
Group entry: 4 animals 150g M, Ch, R, Q per bird in PM
|
2025-04-21 15:38 AN |
Group entry: 4 animals 150g M, Ch, R, Q per bird in PM
|
2025-04-21 15:00 AMS |
Right foot looks good. Ont he L foot you can make out a demarcation where the pododermatitis lesion is continuing to heal, but there is no swelling, erythema, discharge, or other abnormalities. Much improved. p is not able to fly. Appears that p can fold the L wing in normally, but has to try multiple times to fold the R wing and hikes up at the shoulder. Recommend CT as next step for evaluation since radiographs did not show an obvious abnormality in this region.
AMS
|
2025-04-20 09:50 BT |
Group entry: 4 animals 150g M, Ch, R, Q per bird in PM
VitaHawk: Friday Only: Sprinkle 1/2 teaspoon per bird on food in PM.
|
2025-04-19 09:25 KT |
Group entry: 4 animals 150g M, Ch, R, Q
|
2025-04-18 15:50 BT |
Group entry: 5 animals 150g M, Ch, R, Q per bird in PM
VitaHawk: Friday Only: Sprinkle 1/2 teaspoon per bird on food in PM.
|
2025-04-17 15:35 PM |
Group entry: 5 animals 150g R, Q per bird in PM
|
2025-04-16 15:29 BT |
Group entry: 5 animals 150g M, Ch, R, Q per bird in PM
VitaHawk: Friday Only: Sprinkle 1/2 teaspoon per bird on food in PM.
|
2025-04-15 16:19 AN |
Group entry: 5 animals 150g M, Ch, R, Q per bird in PM
|
2025-04-14 15:50 AN |
Group entry: 5 animals 150g M, Ch, R, Q per bird in PM
|
2025-04-14 09:58 AMS |
======= TREATMENT PLAN ======= NPO Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM on 2025-04-15, 2025-04-19 ==============================
|
2025-04-13 10:43 AN |
Group entry: 5 animals 150g M, Ch, R, Q per bird in PM
|
2025-04-11 16:39 BT |
Group entry: 6 animals 150g M, Ch, R, Q per bird in PM
VitaHawk: Friday Only: Sprinkle 1/2 teaspoon per bird on food in PM.
|
2025-04-11 11:12 SAK |
Moved to LFA1
|
2025-04-11 11:11 SAK |
Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM
|
2025-04-10 15:41 AN |
Food: 180g R slit open (do not remove GIT)
|
2025-04-10 08:13 KC |
BAR, flying, 42 g of leftovers
|
2025-04-09 21:24 KC |
Based off of the results of the serum protein electrophoresis, combined with results of the CBC/Chem received on 4/7/25, there is evidence of inflammation. The increased bile acids and amylase may be indicative of acute pancreatitis, which would be supported by the increased alpha 2 globulins on EPH. While it would be ideal to put the patient on an anti-inflammatory at the moment to reduce the evident inflammation, he has been doing really well clinically-- he has been eating and has begun to fly and move around easier on his own. We do not want to have to stress him out unnecessarily with injections or create another reason for food aversion by putting medications in his food. We will monitor him for the rest of the week to make sure he continues to do well clinically. If his symptoms continue, it may be a good idea to evaluate his pancreas with ultrasound for evidence of pancreatitis.
We are also planning to see how he does without bandages on his feet and reassess him next week. Depending on clinical signs, it may be a good to take radiographs to ensure no bony involvement of his pododermatitis lesion. Surgical debridement will need to be discussed as the method of treatment.
Serum chemistry |
Collection date | 2025-04-07 | AST | 53 U/L | Phos | 4.1 mg/dl | BA | 119 umol/L | TP | 5.6 g/dl | CK | 2332 U/L | Alb | 0.0 g/dl | UA | 18.0 mg/dl | Glob | 0.0 g/dl | Glu | 230 mg/dl | K+ | 3.2 mmol/l | Ca | 10.5 mg/dl | Na+ | 145 mmol/l | | | AMY | 2459 U/L | Hem 0, Lip 0, Ict 0 |
|
CBC |
Collection date | 2025-04-07 | WBC count | 26600 | Corrected count | 26600 | Hets/Neut | 60% - 15960 | Bands | 0+ | Toxics | 0+ | Lymphs | 31% - 8246 | Eos | 4% - 1064 | Mono | 5% - 1330 | Baso | 0% - 0 | Thrombocytes | adequate | PI | 1 | Hemoproteus | NEG | Leukocytozoon | NEG | Plasmodium | NEG | Read by | UMiami Avian & Wildlife Lab | W BC Morphology: Reactive monocytes [Rare ] |
|
|
2025-04-09 15:38 BT |
Food: 177g R slit open (do not remove GIT)
|
2025-04-09 10:07 KC |
Checked on patient this morning and he was BAR and on the perch. He seemed to have eaten well but he left behind various spines scattered around the enclosure. He had normal mutes and no pellets.
|
2025-04-09 09:50 re |
======= TREATMENT PLAN ======= Food: 180g R slit open (do not remove GIT) SID Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM on 2025-04-11 ============================== NPO on 4/14/25
|
2025-04-09 09:45 AMS |
======= TREATMENT PLAN ======= Food: 180g R slit open (do not remove GIT) SID Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM on 2025-04-11 ============================== d/c Ca glubionate
|
2025-04-09 09:33 SAK |
======= TREATMENT PLAN ======= Food: 180g R slit open (do not remove GIT) SID Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM on 2025-04-11 Ca Glubionate: 2 ml (23 mg/ml soln) SID PO ==============================
|
2025-04-08 16:51 AN |
Food: 180g R slit open (do not remove GIT) Ca Glubionate: 2 ml (23 mg/ml soln) PO (Can put on food if eating on own. Give with gavage feeding if not eating on own.)
Had 40g leftover but it was mainly skin and a ribcage
|
2025-04-07 11:27 SAK |
Noted mild soft tissue swelling at the right carpus dorsally. Similar to what was palpated at presentation.
The left foot plantar lesion is static. The duoderm and tegaderm were not present on the foot. Left foot unbandaged since it is still raining.
Gave Ceftiofur IM pectoral.
AMS
|
2025-04-07 11:11 re |
Weight: 1870 grams, BCS: 2.5 ------------- LASER THERAPY ---------------- Power (joules): 77 Time: 2:34 Location: Left plantar foot
Drew 2 ml from right basilic vein for in house chem and UM chem/eph/cbc.
Weight gain 9% BW
Serum chemistry |
Collection date | 2025-04-07 | AST | 31 U/L | Phos | 4.0 mg/dl | BA | 34 umol/L | TP | 5.4 g/dl | CK | 1909 U/L | Alb | 1.4 g/dl | UA | 17.5 mg/dl | Glob | 4.0 g/dl | Glu | 225 mg/dl | K+ | 4.0 mmol/l | Ca | 10.6 mg/dl | Na+ | 139 mmol/l | | | AMY | 0 U/L | Hem 0, Lip 1, Ict 0 |
|
|
2025-04-07 11:01 AN |
Food: 180g R slit open (do not remove GIT) Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM Ca Glubionate: 2 ml (23 mg/ml soln) PO (Can put on food if eating on own. Give with gavage feeding if not eating on own.)
was flying to high perch from the ground as well as flying back and forth from perches BAR/NO pellet/ Normal mutes
|
2025-04-07 08:32 SAK |
======= TREATMENT PLAN ======= Food: 180g R slit open (do not remove GIT) SID Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM on 2025-04-11 Ca Glubionate: 2 ml (23 mg/ml soln) SID PO (Can put on food if eating on own. Give with gavage feeding if not eating on own.) Blood: ============================== Updated
|
2025-04-06 09:59 BT |
Food: 195g R slit open (do not remove GIT)
Ca Glubionate: 2 ml (23 mg/ml soln) on food
|
2025-04-06 08:13 KC |
BAR, no pellet, normal mutes
|
2025-04-05 15:08 BT |
I checked in the afternoon and found the spine and guts of the rabbit. So the bird did not eat the entire thing as I thought earlier, but definitely ate the majority. I removed the leftovers.
|
2025-04-05 10:49 BT |
Food: Offered a skinned rabbit and three skinned mice. Volunteers fed it out before Ca Glubionate added but the good news is the rabbit was eaten entirely and only a scrap or two of mouse remained. Bird was up on the high perch with a satisfyingly full looking crop. I guess we can start the Ca Gl. tomorrow!
|
2025-04-05 08:56 BT |
Definitely ate the majority of food offered yesterday PM. Will try Ca GL in food today.
|
2025-04-05 08:35 ob |
Roughly four bodies left shredded. Moved coyote decoy leg. Left alone to see if he would eat the rest BAR, Normal mutes
|
2025-04-04 17:24 AMS |
======= TREATMENT PLAN ======= Food: 180g R slit open (do not remove GIT) SID Assisted feed: 50-60ml Emeraid Carnivore SID , If not eating Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM on 2025-04-07, 2025-04-11 Ca Glubionate: 2 ml (23 mg/ml soln) SID PO (Can put on food if eating on own. Give with gavage feeding if not eating on own.) ============================== added Ca glubionate
|
2025-04-04 15:38 BT |
Food: 4 rats and 2 mice, skinned. All placed on coyote decoy leg.
|
2025-04-04 15:32 KC |
Removed the donut bandages because it is supposed to rain this weekend and we do not want the rain causing tissue maceration and infection. On the affected foot (left), we flushed the wound with betadine, put on a circular DuoDerm dressing and covered it with a Tegaderm bandage.
We drew 1.5 mL of blood from the left ulnar vein and ran an in-house chemistry and PCV/TS and looked at a blood smear.
The blood smear demonstrated adequate erythrocyte cellularity and morphology in the monolayer with no inclusions. There was no evidence of hemoparasites at the feathered edge. There were 2-3 WBCs/hpf, mostly heterophils, and 3-4 thrombocytes/hpf with normal morphology. No polychromasia or anisocytosis was detected.
The only major abnormality on the serum chemistyr was the calcium. The total calcium was low so we ran an ionized calcium to follow up, which was normal. To be safe, we added on calcium glubionate 23 mg/mL (25 mg/kg) 1.87 mL PO BID.
Some potential causes for hypocalcemia include hypoparathyroidism, hypovitaminosis D, maldigestion, malabsorption, EDTA, PLE, eclampsia, renal failure, hypoalbuminemia, ethylene glycol toxicosis, lab error and phosphate enemas. The most likely causes in this case are EDTA, since the patient was taking Ca EDTA for high lead levels and it fits the onset of clinical signs, renal failure, since Ca EDTA can be hard on the kidneys and hypocalcemia is associated with acute kidney injury and lab error, because there was a disconnect between the shockingly low total calcium and the ionized calcium within normal limits. We will re-evaluate on Monday 4/7/25.
PCV/TP |
Collection date | 2025-04-04 15:32:00 | PCV | 44 % | TS | 6.0 g\dl | Serum | |
|
|
2025-04-04 13:23 re |
|
2025-04-03 11:49 re |
Patient was offered 360g of rats, mice, and one chick. Another BLVU (Zombie) was introduced to the aviary to offer socialization stimulation to the patient. Both vultures began attacking one another within a few minutes. They were separated by staff after a moment, then observed preening and smoothing out ruffled feathers. After several minutes Zombie began antagonizing 064, who ran away from Zombie after a brief scuffle. Zombie continued to chase 064 until staff intervened once again and removed Zombie from the aviary.
Afterwards staff re-entered and placed a hollowed out coyote prop on the ground to simulate a dead animal. Previously offered whole food was skinned and placed in and around prop. 064 began to investigate food once staff left aviary, so more skinned rats were offered to try to stimulate a response. A total of 5 rats, 4 mice and 1 chick were offered.
|
2025-04-03 10:41 KC |
Weight: 1720 grams Food: 180g R slit open (do not remove GIT) Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM Midazolam: 0.07 ml IM Meloxicam: 0.37 ml (5 mg/ml)SQ
Assist fed patient Emeraid Carnivore 40 mL PO by gavage
|
2025-04-03 10:14 SAK |
======= TREATMENT PLAN ======= Food: 180g R slit open (do not remove GIT) SID Ceftiofur Excede Q 96 hr: 0.37 ml (100 mg/ml) IM on 2025-04-07, 2025-04-11 ==============================
|
2025-04-03 08:06 KC |
BAR, normal mutes, no pellet, 175 g leftovers
|
2025-04-02 16:00 BT |
Food: 181g R slit open (do not remove GIT) variety of R, M, Ch offered.
|
2025-04-02 10:30 AMS |
Food: 40ml Emeraid Carnivore via gavage - did not immediately regurgitate Midazolam: 0.07 ml (5mg/ml Inj) IM (0.2mg/kg dose for appetite stimulation) - L pectoral
There is a 2cm ovoid partial thickness cutaneous lesion to the right of the keel where the skin is dry and peeling
Foot bandages intact, clean
AMS
|
2025-04-02 10:09 AMS |
======= TREATMENT PLAN ======= Food: 180g R slit open (do not remove GIT) SID Midazolam: 0.07ml (5mg/ml Inj) SID IM (0.2mg/kg dose for appetite stimulation) ==============================
|
2025-04-02 08:10 re |
Bandages still in place, left 82g rat plus whole rabbit from yesterday
|
2025-04-01 16:52 SAK |
======= TREATMENT PLAN ======= Food: 180g R slit open (do not remove GIT) SID ==============================
|
2025-04-01 16:51 SAK |
Food: 1 whole rabbit cut open
|
2025-04-01 16:46 SAK |
Drank water when water tub filled.
|
2025-04-01 09:26 KC |
Food: 92 g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO
BAR, normal mutes, no pellet, 181 g left over
|
2025-04-01 08:33 re |
======= TREATMENT PLAN ======= Food: 90g R slit open (do not remove GIT) BID ==============================
|
2025-03-31 16:28 KC |
------------- LASER THERAPY ---------------- Power (joules): 77 Time: 2:34 Location: Left plantar aspect
Lesion on left plantar aspect of left foot indicative of pododermatitis grade III/V - on the center of the foot, raised, with central "core" Bandage change on left foot (donut bandage)-- applied triple antibiotic cream on lesion and Tegaderm, foam, Vetrap, Ioban, duct tape Similar foam bandage added to right foot without triple antibiotic and Tegaderm
Moved to FA1
Blood was drawn from the left ulnar vein and submitted for aspergillosis testing-- antibody, gliotoxin and galactomannan-- due to results of protein electrophoresis
KC/AMS
Sample |
Collection date | 2025-03-31 | Type | plasma | Notes:
| Results: Aspergillus : Antibody test = negative |
|
|
2025-03-31 16:24 KC |
Food: 186 g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO
|
2025-03-31 11:41 re |
NPO
BAR, did not eat overnight, normal mutes, no pellet
Given water dish
|
2025-03-31 09:22 re |
======= TREATMENT PLAN ======= Food: 90g R slit open (do not remove GIT) BID TMS: 2.01 ml (48 mg/ml) BID PO Meloxicam: 1.30 ml (1.5 mg/ml soln) BID PO ============================== d/c cerenia
|
2025-03-30 15:18 AN |
Food: 94g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO
Gave meds orally but left food in its cage since it regurgitated in the am.
|
2025-03-30 09:04 BT |
Food: Assist fed -87g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SQ Not eating on own. no feces or pellet, 166g. leftover.
gave meds PO and assist fed but patient regurgitated immediately thereafter.
|
2025-03-29 15:48 BT |
Food: 103 g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO
|
2025-03-29 09:05 BT |
Food: 90g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SQ BAR, normal mutes, not eating well. 174g leftover
|
2025-03-28 15:46 BT |
Food: 99g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SQ Blood: lead
|
2025-03-28 10:46 re |
Weight: 1870 grams Food: 90g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SQ
Weight loss 3% (-64g)
|
2025-03-28 09:00 SAK |
154g LO from 3/27/25
Lead decreased from 18ug/dL at presentation to 6.4ug/dL. No further chelation needed. AMS
Blood lead |
Collection date | 2025-03-28 | Level | 6.40 ug/dL |
|
|
2025-03-27 17:11 SAK |
Cleaned plantar surface of L foot with diluted betadine. Applied triple AB ointment to pododerm lesion and placed a telfa. Foot put into a pool noodle boot to relieve the pressure off of the lesion. Boot attached with tape, vet wrap, and external layer of duct tape. Check daily.
------------- LASER THERAPY ---------------- Power (joules): 77 Time: 2:34 Location: Left foot plantar surface
|
2025-03-27 17:11 SAK |
======= TREATMENT PLAN ======= Food: 90g R slit open (do not remove GIT) BID TMS: 2.01 ml (48 mg/ml) BID PO Meloxicam: 1.30 ml (1.5 mg/ml soln) BID PO Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SID SQ ==============================
|
2025-03-27 16:03 BT |
Food: 90g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SQ
|
2025-03-27 09:09 SAK |
Left 153g from 3/26/25 Urates/feces present
|
2025-03-27 08:48 BT |
Food: 90g R slit open (do not remove GIT) TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SQ Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) PO until 2025-03-27
|
2025-03-26 16:14 re |
Food: 93g R slit open (do not remove GIT) SQ fluids: 68mL until 2025-03-26 TMS: 2.01 ml (48 mg/ml) PO Meloxicam: 1.30 ml (1.5 mg/ml soln) PO CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26
|
2025-03-26 11:22 SAK |
Updated medication doses based on a latest weight of 1934 g
|
2025-03-26 11:20 SAK |
Weight: 1934 grams Weight gain 7% BW
87g leftovers - No regurgitation
Pellet/urates/feces present
|
2025-03-26 09:06 BT |
Food: 101g R slit open (do not remove GIT) SQ fluids: 68mL until 2025-03-26 TMS: 1.88 ml (48 mg/ml) PO Meloxicam: 1.21 ml (1.5 mg/ml soln) PO CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26 Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SQ Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) PO until 2025-03-27
|
2025-03-25 16:58 re |
Plantar pododermatitis lesion noted on left foot when anesthetizing for radiographs - grade III/V. Area was cleaned with betadine and an interdigital bandage was placed after completion of radiographs. AMS
Imagery report |
Date | 2025-03-25 | Type | Radiograph | Performed by | re | Positioning | | Equipment | | Location | AUCVM | Anesthesia | ISO via mask | Comments | 1. soft tissue swelling at R carpus - bone/joint abnormalities not appreciated
2. healed fracture of the proximal diaphysis of the R tibiotarsus and fibula with no significant displacement or angulation, the bone bridging around the fracture is smooth
3. no evidence of osteomyelitis of the L foot |
|
|
2025-03-25 16:33 re |
Electrophoresis Comments The total protein is increased. This may reflect mild patient or sample dehydration. By percent total protein, the alpha 2 and gamma globulin fractions are increased. Alpah 2 globulins reflect acute inflammation and the gamma globulins reflect an active humoral immune response. Consider infectious processes including chlamydiosis and aspergillosis. Followup EPH should have prognostic value in this case.
Serum chemistry |
Collection date | 2025-03-25 | AST | 21 U/L | Phos | 5.7 mg/dl | BA | 4 umol/L | TP | 6.6 g/dl | CK | 768 U/L | Alb | 0.0 g/dl | UA | 1.2 mg/dl | Glob | 0.0 g/dl | Glu | 223 mg/dl | K+ | 4.0 mmol/l | Ca | 10.8 mg/dl | Na+ | 149 mmol/l | | | AMY | 1139 U/L | Hem 0, Lip 0, Ict 0 |
|
CBC |
Collection date | 2025-03-25 | WBC count | 23200 | Corrected count | 23200 | Hets/Neut | 70% - 16240 | Bands | 0+ | Toxics | 0+ | Lymphs | 18% - 4176 | Eos | 5% - 1160 | Mono | 5% - 1160 | Baso | 2% - 464 | Thrombocytes | adequate | PI | 1 | Hemoproteus | NEG | Leukocytozoon | NEG | Plasmodium | NEG | Read by | UMiami Avian & Wildlife Lab | W BC Morphology: Reactive lymphocytes [Rare ] |
|
|
2025-03-25 16:24 re |
Food: 84g R slit open (do not remove GIT) SQ fluids: 60mL until 2025-03-26 TMS: 1.88 ml (48 mg/ml) PO Meloxicam: 1.21 ml (1.5 mg/ml soln) PO CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26 Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SQ
PCV/TP |
Collection date | 2025-03-25 16:24:00 | PCV | 44 % | TS | 7.2 g\dl | Serum | |
|
|
2025-03-25 14:27 re |
======= TREATMENT PLAN ======= Food: 90g R slit open (do not remove GIT) BID SQ fluids: 68mL BID until 2025-03-26 TMS: 1.88 ml (48 mg/ml) BID PO Meloxicam: 1.21 ml (1.5 mg/ml soln) BID PO CaEDTA: 0.36 ml (250 mg/ml inj) BID SQ until 2025-03-26 Cerenia (Maropitant): 0.18 ml (10 mg/ml Injectable) SID SQ Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) SID PO until 2025-03-27 ============================== added TMS and Cerenia
|
2025-03-25 11:27 re |
NPO SQ fluids: 68mL until 2025-03-26 CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26 BAR, normal mutes, one pellet, three pieces of regurgitated food
|
2025-03-24 17:02 AN |
Food: 904g R slit open (do not remove GIT) SQ fluids: 68mL until 2025-03-26 Meloxicam: 1.21 ml (1.5 mg/ml soln) PO CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26
|
2025-03-24 09:32 AN |
Food: 94g R slit open (do not remove GIT) SQ fluids: 68mL until 2025-03-26 Meloxicam: 1.21 ml (1.5 mg/ml soln) PO CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26 Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) PO
BAR, one pellet, no leftovers, normal mutes
|
2025-03-23 17:01 BT |
Food: 89g R slit open (do not remove GIT) SQ fluids: 68mL until 2025-03-26 Meloxicam: 1.21 ml (1.5 mg/ml soln) PO CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26
|
2025-03-23 11:10 BT |
Food: 90g R slit open (do not remove GIT) SQ fluids: 68mL until 2025-03-26 Meloxicam: 1.21 ml (1.5 mg/ml soln) PO CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26 Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) PO
60 g leftover. Looks partially digested. Patient BAR.
|
2025-03-22 16:21 BT |
Food: 90g R slit open (do not remove GIT) SQ fluids: 68mL until 2025-03-26 Meloxicam: 1.21 ml (1.5 mg/ml soln) PO CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26
|
2025-03-22 10:44 BT |
Food: 92g R slit open (do not remove GIT) SQ fluids: 68mL until 2025-03-26 Meloxicam: 1.21 ml (1.5 mg/ml soln) PO CaEDTA: 0.36 ml (250 mg/ml inj) SQ until 2025-03-26 Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) PO
|
2025-03-21 16:07 SAK |
Drew 1ml from left basilic vein for lead, pcv, ts.
PCV/TP |
Collection date | 2025-03-21 16:07:00 | PCV | 47 % | TS | 6.8 g\dl | Serum | |
|
Blood lead |
Collection date | 2025-03-21 | Level | 18.10 ug/dL |
|
|
2025-03-21 16:07 re |
======= TREATMENT PLAN ======= Food: 90g R slit open (do not remove GIT) BID SQ fluids: 68mL BID until 2025-03-26 Meloxicam: 1.21 ml (1.5 mg/ml soln) BID PO CaEDTA: 0.36 ml (250 mg/ml inj) BID SQ until 2025-03-26 Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) SID PO ============================== added fluids and CaEDTA
|
2025-03-21 14:44 re |
======= TREATMENT PLAN ======= Food: 90g R slit open (do not remove GIT) BID Meloxicam: 1.21 ml (1.5 mg/ml soln) BID PO Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) SID PO ==============================
|
2025-03-21 14:43 re |
Sample |
Collection date | 2025-03-21 | Type | choanal/cloacal swab | Notes:
| Results: AI PCR : Not detected |
|
|
2025-03-21 10:42 SAK |
======= TREATMENT PLAN ======= Food: 90g R slit open (do not remove GIT) BID Meloxicam: 0.36 ml (5 mg/ml (Injectable)) BID SQ (Switch to oral once eating) Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) SID PO ==============================
|
2025-03-21 10:40 SAK |
======= TREATMENT PLAN ======= Food: 90g R (do not remove GIT) BID Meloxicam: 0.36 ml (5 mg/ml (Injectable)) BID SQ (Switch to oral once eating) Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) SID PO ==============================
|
2025-03-21 10:40 SO |
======= TREATMENT PLAN ======= Meloxicam: 1.21 ml (1.5 mg/ml soln) BID PO Isoxsuprine: 0.45 ml (40mg/ml ORAL susp) SID PO until 2025-03-31 ==============================
|
2025-03-21 10:34 SO |
Weight: 1812 grams, BCS: 3.0
------------- PHYSICAL EXAM FINDINGS ---------------- Attending Veterinarian: Dr. Seth Oster Observational examination Mentation: BAR Posture: Normal Vital stats Heart rate: 300 Respiratory rate: 80 Auscultation: WNL Mucous membranes: Mosit Hydration: Euhydration Oral cavity: WNL Choana: WNL Glottis: WNL Beak: WNL Cere/nares: WNl Eyes: WNL Ears: WNL Crop: WNL Feather quality: Tail feathers missing, but new growth present Integument: WNL Wings: Edema of the Right carpus and metacarpus. No palpable instability or crepitance Legs/Feet: WNL Neurologic: WNL Ceolom: WNl Vent: WNl Droppings: WNL Uropygial gland: WNL Plan: Gave 0.36mls meloxicam IM, will start oral meloxicam when eating. Start oral SID isoxsuprine. AI swab taken. When cleared, rads to evaluate wing tip.
|